Ledger.Open graph →
SEC Form D · filed September 23, 2022

Arpeggio Biosciences, Inc

Offering
$20.3M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Eric G. Martin · BOULDER, COExecLaura G. Norris · BOULDER, COExec · DirectorTimothy G. Read · BOULDER, COExec · DirectorJude Panetta · Mt. Olive, NJExec · DirectorJoseph G. Azofeifa · BOULDER, COExec · DirectorAmit G. Mehta · BOULDER, CODirectorDaniel K. Flynn · San Jose, CAExec · DirectorShekhar K. Varanasi · San Jose, CAExec · DirectorAshley J. Gautreaux · Charlotte, NCExec · DirectorCarleton Miller · Mt. Olive, NJExec · DirectorEric G. Martin · BOULDER, COExecAmit G. Mehta · BOULDER, CODirectorBrian Krolicki · Mt. Olive, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗